Jim Cramer on ARS Pharmaceuticals: “It's a Great Flier”
ARS Pharmaceuticals (NASDAQ:SPRY) is a biopharmaceutical company focused on helping patients and caregivers manage severe allergic reactions, with its product neffy, a nasal epinephrine spray approved...